Intratumoral CAN1012(selective TLR7 Agonist) in Subjects with Solid Tumors
NCT05580991 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2025-02-13
Summary
To evaluate CAN1012 when administered by IT injection to subjects with advanced solid tumors who are not candidates for standard therapy.
Conditions
Interventions
- DRUG
-
CAN1012
CAN1012 IT injection (once every 4 weeks)
Sponsors & Collaborators
-
Canwell Biotech Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-09
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors
NCT05990452 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors
NCT05564858 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Investigate FP002 in Subjects With Advanced Malignancies
NCT05982080 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
NCT07103668 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors
NCT05205408 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
NCT06519669 ·Status: TERMINATED ·Phase: NA
-
Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid Tumors
NCT05505877 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score
NCT04989855 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC
NCT02421640 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor
NCT06166472 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid Tumors
NCT05122572 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors
NCT05499715 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
NCT05877924 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors
NCT03312842 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
NCT05170958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Risk Factors and Long-term Impact of ICIs
NCT05754983 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer
NCT03728556 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GC203 TIL in Advanced Solid Tumors (NF)
NCT07256756 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Evaluation of ICP-B794 in Patients With Advanced Solid Tumors
NCT07136558 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors
NCT05924906 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921 ·Status: RECRUITING ·Phase: PHASE1
-
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
NCT03930498 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)
NCT05652712 ·Status: UNKNOWN
-
A Phase I Study of CS1002 in Subjects With Advanced Solid Tumors
NCT04338724 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NCT07136142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2